SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001264931-15-000027
Filing Date
2015-01-20
Accepted
2015-01-20 17:17:58
Documents
2
Period of Report
2015-01-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 imun8k.htm 8-K 21479
2 IMMUNE THERAPEUTICS, INC. ANNOUNCES APPOINTMENT OF NEW DIRECTOR AND ACCEPTANCE O ex99_1.htm EX-99.1 16681
  Complete submission text file 0001264931-15-000027.txt   39496
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54933 | Film No.: 15536769
SIC: 2834 Pharmaceutical Preparations